title: Conformation and Linkage Studies of Specific Oligosaccharides Related to H1N1, H5N1, and Human Flu for Developing the Second Tamiflu.
abstract: The interaction between viral HA (hemagglutinin) and oligosaccharide of the host plays an important role in the infection and transmission of avian and human flu viruses. Until now, this interaction has been classified by sialyl(α2-3) or sialyl(α2-6) linkage specificity of oligosaccharide moieties for avian or human virus, respectively. In the case of H5N1 and newly mutated flu viruses, classification based on the linkage type does not correlate with human infection and human-to-human transmission of these viruses. It is newly suggested that flu infection and transmission to humans require high affinity binding to the extended conformation with long length sialyl(α2-6)galactose containing oligosaccharides. On the other hand, the avian flu virus requires folded conformation with sialyl(α2-3) or short length sialyl(α2-6) containing trisaccharides. This suggests a potential future direction for the development of new species-specific antiviral drugs to prevent and treat pandemic flu.
authors.affiliation: College of Health Science, Honam University, Gwangju 506-714, Republic of Korea.
authors.forename: Eunsun
authors.initials: E
authors.lastname: Yoo
keywords: Conformation; H1N1; H5N1; Linkage type; Oligosaccharide; Tamiflu
references.citation: J Mol Biol. 2009 Mar 27;387(2):465-91
references.pmid: 19356594
references.citation: Nat Rev Microbiol. 2006 Nov;4(11):857-64
references.pmid: 17013397
references.citation: Chem Biol. 2007 Aug;14(8):873-4
references.pmid: 17719484
references.citation: PLoS One. 2013 Jul 23;8(7):e70005
references.pmid: 23894575
references.citation: Nat Biotechnol. 2008 Jan;26(1):107-13
references.pmid: 18176555
references.citation: Lancet. 2000 Mar 4;355(9206):827-35
references.pmid: 10711940
references.citation: Proc Natl Acad Sci U S A. 2008 May 27;105(21):7558-63
references.pmid: 18508975
references.citation: Chem Biol. 2009 Aug 28;16(8):803-14
references.pmid: 19716471
references.citation: Science. 2013 Apr 26;340(6131):414-5
references.pmid: 23620023
references.citation: Respir Res. 2007 Oct 25;8:73
references.pmid: 17961210
references.citation: Trends Microbiol. 2012 Jan;20(1):11-20
references.pmid: 22153752
references.citation: J Virol. 2005 Apr;79(7):4201-12
references.pmid: 15767421
references.citation: Antiviral Res. 2012 Dec;96(3):391-404
references.pmid: 23022351
references.citation: Virology. 2012 Jan 5;422(1):105-13
references.pmid: 22056389
references.citation: Infect Disord Drug Targets. 2007 Dec;7(4):294-303
references.pmid: 18220961
references.citation: Nature. 2009 Jun 18;459(7249):931-9
references.pmid: 19525932
references.citation: Biochem Pharmacol. 2013 Mar 15;85(6):727-44
references.pmid: 23270991
references.citation: Lancet. 1998 Feb 14;351(9101):472-7
references.pmid: 9482438
references.citation: Glycoconj J. 2010 Aug;27(6):561-70
references.pmid: 20734133
references.citation: Biochim Biophys Acta. 2014 Apr;1838(4):1153-68
references.pmid: 24161712
references.citation: J Microbiol Biotechnol. 2011 May;21(5):449-54
references.pmid: 21617340
references.citation: Curr Opin Virol. 2012 Apr;2(2):160-7
references.pmid: 22445963
references.citation: Proc Natl Acad Sci U S A. 2008 Feb 26;105(8):2800-5
references.pmid: 18287068
references.citation: J Virol. 2007 Jul;81(13):6890-8
references.pmid: 17459930
references.citation: Science. 2004 Mar 19;303(5665):1866-70
references.pmid: 14764887
references.citation: J Virol. 2012 Jan;86(2):982-90
references.pmid: 22072785
references.citation: N Engl J Med. 2009 Dec 3;361(23):2296-7
references.pmid: 19907034
references.citation: Science. 2006 Apr 21;312(5772):404-10
references.pmid: 16543414
references.citation: PLoS Pathog. 2011 Oct;7(10):e1002249
references.pmid: 22028647
references.citation: Nature. 1983 May 5-11;303(5912):41-4
references.pmid: 6188957
references.citation: Curr Opin Virol. 2011 Dec;1(6):563-73
references.pmid: 22440914
references.citation: PLoS Pathog. 2013 Mar;9(3):e1003223
references.pmid: 23516363
references.citation: Protein Sci. 2009 Apr;18(4):707-15
references.pmid: 19309695
references.citation: J Biol Chem. 2010 Oct 29;285(44):34016-26
references.pmid: 20724471
references.citation: Top Curr Chem. 2015;367:1-28
references.pmid: 23873408
references.citation: J Infect Dis. 2006 Nov 1;194 Suppl 2:S119-26
references.pmid: 17163384
references.citation: Curr Opin Virol. 2011 Dec;1(6):635-42
references.pmid: 22440921
references.citation: Emerg Infect Dis. 2006 Jun;12(6):881-6
references.pmid: 16707041
references.citation: J Antimicrob Chemother. 2006 Oct;58(4):723-32
references.pmid: 16891631
references.citation: Antiviral Res. 2013 May;98(2):174-85
references.pmid: 23523943
references.citation: Adv Virol. 2013;2013:121924
references.pmid: 23365574
references.citation: J Virol. 2010 Oct;84(19):9800-9
references.pmid: 20660186
references.citation: J Virol. 2008 Nov;82(21):10493-501
references.pmid: 18715929
references.citation: J Virol. 2012 Feb;86(3):1411-20
references.pmid: 22090115
references.citation: Nature. 2006 Sep 7;443(7107):45-9
references.pmid: 16915235
references.citation: Proc Natl Acad Sci U S A. 2001 Sep 25;98(20):11181-6
references.pmid: 11562490
references.citation: Antiviral Res. 2011 Jun;90(3):205-12
references.pmid: 21514326
references.citation: Virology. 2005 Apr 10;334(2):276-83
references.pmid: 15780877
references.citation: Clin Infect Dis. 2009 Jan 1;48 Suppl 1:S3-13
references.pmid: 19067613
references.citation: Science. 2013 Apr 12;340(6129):129-30
references.pmid: 23580498
references.citation: J Med Chem. 2000 Sep 21;43(19):3482-6
references.pmid: 11000002
references.citation: Nature. 1983 May 5-11;303(5912):35-40
references.pmid: 6843658
references.citation: Virol J. 2007 May 09;4:42
references.pmid: 17490484
references.citation: Science. 2009 Mar 20;323(5921):1560-1
references.pmid: 19299601
references.citation: Antimicrob Agents Chemother. 2001 Apr;45(4):1162-7
references.pmid: 11257030
references.citation: J Mol Biol. 2008 Sep 19;381(5):1382-94
references.pmid: 18672252
references.citation: Virology. 2003 May 10;309(2):209-18
references.pmid: 12758169
references.citation: Clin Infect Dis. 2010 May 1;50(9):1252-5
references.pmid: 20345239
references.citation: Angew Chem Int Ed Engl. 2008;47(10):1910-2
references.pmid: 18232036
references.citation: PLoS One. 2010 Jun 21;5(6):e11158
references.pmid: 20574518
references.citation: Nat Chem Biol. 2006 May;2(5):238-48
references.pmid: 16619023
references.citation: Science. 2001 Sep 7;293(5536):1840-2
references.pmid: 11546875
references.citation: N Engl J Med. 2005 Nov 24;353(21):2209-11
references.pmid: 16306515
references.citation: Science. 2005 Oct 7;310(5745):77-80
references.pmid: 16210530
references.citation: Nature. 2008 Jun 26;453(7199):1258-61
references.pmid: 18480754